Comments on: ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News http://www.xconomy.com/boston/2009/03/11/immunogen-drug-nears-finish-line-surface-logix-latches-onto-20m-athenahealth-ceo-bush-talks-stimulus-more-boston-area-life-sciences-news/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 16:55:51 -0600 http://wordpress.org/?v=2.8.6 hourly 1 By: ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News | Polymer Info http://www.xconomy.com/boston/2009/03/11/immunogen-drug-nears-finish-line-surface-logix-latches-onto-20m-athenahealth-ceo-bush-talks-stimulus-more-boston-area-life-sciences-news/comment-page-1/#comment-49885 ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News | Polymer Info Wed, 11 Mar 2009 16:23:56 +0000 http://www.xconomy.com/?p=15694#comment-49885 [...] More:  ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimu... [...] [...] More:  ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimu… [...]

]]>